Impact of drug distribution into adipose on tissue function: The cholesteryl ester transfer protein (CETP) inhibitor anacetrapib as a test case
Abstract Anacetrapib is an inhibitor of cholesteryl ester transfer protein (CETP) previously under development as a lipid‐modifying agent that reduces LDL‐cholesterol and increases HDL‐cholesterol in hypercholesterolemic patients. Anacetrapib demonstrates a long terminal half‐life and accumulates in...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2019-12-01
|
| Серія: | Pharmacology Research & Perspectives |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1002/prp2.543 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|